NKGen Biotech, Inc. Warrants
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NKGen Biotech, Inc. Warrants generated cash of -$21,948,000, which is more than the previous year. Cash used in financing activities reached the amount of $22,155,000 last year. Net change in cash is therefore $159,000.
Cash Flow
| 2021 | -19.54M | -459K | 20.15M |
|---|---|---|---|
| 2022 | -22.55M | -163K | 22.48M |
| 2023 | -21.94M | -48K | 22.15M |
NKGNW Cash Flow Statement (2021 – 2023)
| 2023 | 2022 | 2021 | |
|---|---|---|---|
Cash at beginning of period | 117K | 351K | 199K |
Operating activities | |||
Net income | -82.95M | -26.75M | -23.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 1.20M | 1.65M | 1.24M |
Stock-based compensation expense | 4.13M | 69K | 93K |
| Deferred income tax benefit | 4.13M | 69K | 93K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 29K | -29K | 111K |
Inventories | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 |
Cash generated by operating activities | -21.94M | -22.55M | -19.54M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | -171.61M |
Investments In Property Plant And Equipment | -48K | -163K | -459K |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -48K | -163K | -459K |
Financing activities | |||
Common Stock Issued | 1.66M | 161K | 63K |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 26.20M | 22.32M | -404K |
Cash used in financing activities | 22.15M | 22.48M | 20.15M |
Net Change In Cash | 159K | -234K | 152K |
Cash at end of period | 276K | 117K | 351K |